To the Editor [1]

Canadian Journal of Cardiology

Volumn 23, Issue 5, 2007, Pages 397-398

  Vos, Eddie ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ATORVASTATIN; GLYCERYL TRINITRATE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PLACEBO; SIMVASTATIN; HEPTANOIC ACID DERIVATIVE; PYRROLE DERIVATIVE;

CARDIOVASCULAR RISK; CLINICAL TRIAL; DRUG COST; DRUG DOSE COMPARISON; DRUG MEGADOSE; HEART INFARCTION; HIGH RISK PATIENT; HUMAN; HYPERCHOLESTEROLEMIA; LETTER; LOW DRUG DOSE; META ANALYSIS; MORTALITY; PRIMARY PREVENTION; STABLE ANGINA PECTORIS; SURVIVAL; SYSTEMATIC REVIEW; BLOOD; CANADA; DYSLIPIDEMIA; NOTE;

CANADA; CHOLESTEROL, LDL; DYSLIPIDEMIAS; HEPTANOIC ACIDS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERCHOLESTEROLEMIA; PYRROLES;

EID: 34249673311     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0828-282X(07)70778-X     Document Type: Letter

References (7)

1. Sever PS, Dahlof B, Poulter NR, et al. Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid Lowering Arm (ASCOT-LLA): A multicentre randomised controlled trial. Lancet 2003;361:1149-58.
2. Vos E, Rose CP. Questioning the benefits of statins. CMAJ 2005;173:1207.
3. Baigent C, Keech A, Kearney PM, et al; Cholesterol Treatment Trialists' (CTT) Collaborators. Efficacy and safety of cholesterol-lowering treatment: Prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet 2005;366:1267-78.
4. Amarenco P, Bogousslavsky J, Callahan A III, et al; Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Investigators. High-dose atorvastatin after stroke or transient ischemic attack. N Engl J Med 2006;355:549-59.
5. Matsuzaki M, Kita T, Mabuchi H, et al; J-LIT Study Group. Japan Lipid Intervention Trial. Large scale cohort study of the relationship between serum cholesterol concentration and coronary events with low-dose simvastatin therapy in Japanese patients with hypercholesterolemia. Circ J 2002;66:1087-95.
6. Dagenais GR, Ahmed Z, Robitaille NM, et al. Total and coronary heart disease mortality in relation to major risk factors - Quebec cardiovascular study. Can J Cardiol 1990;6:59-65.
7. Heart Protection Study Collaboration Group. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: A randomised placebo controlled trial. Lancet 2002;360:7-22.